Images are for illustrative purposes only. Packaging may vary.
Retatrutide · LY-3437943 · CAS 2381089-83-2
Research material provided with clear specifications
and available analytical documentation.
Specifications and laboratory reports are public. Pricing and order requests require a verified research account.
Have questions? Contact us for product details, availability, or bulk inquiries.
Retatrutide is an investigational peptide studied in scientific research. Published research describes its activity at GIP, GLP-1 and glucagon receptors.
This EULIX Research product is supplied as a clearly identified research material with specifications and associated documentation displayed when available.
This product is intended exclusively for laboratory research and analytical purposes. Not for human or veterinary use.
Available analytical documentation is associated with a specific batch. A certificate of analysis (COA) may include:
Testing claims and purity values should be interpreted according to the specific analytical report associated with the product.
Published research from scientific sources. These references are provided for educational purposes and do not validate this EULIX product or its batches.
References checked September 9, 2026. Recent relevant publications are prioritized. Research does not validate EULIX materials or batches.
Clinical study of glycaemic control. Published in The Lancet, June 2026.
Read publication
